Roberto Vendrell, MD
Gastroenterology · Guaynabo, PRNPI 1407830250
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 68.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $8,627 and has fallen 84.2% since, to $1,363 in 2025. Among gastroenterology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $147.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Johnson & Johnson$3K
- E.r. Squibb & Sons, L.L.C.$526
- Organon$257
- Boston Scientific$204
- Pfizer Pharmaceuticals LLC$158
- plus $570 from 9 others
What the payments were for
- Consulting fees$2,27515%
- Speaking & faculty fees$7,50050%
- Food & beverage$5,19134%
- Education$1161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $10,335 |
| Johnson & Johnson(2 entities) | 10 | $3,032 |
| E.r. Squibb & Sons, L.L.C. | 16 | $526 |
| Organon | 11 | $257 |
| Boston Scientific | 2 | $204 |
| Pfizer Pharmaceuticals LLC | 3 | $158 |
| Olympus Latin America, Inc. | 1 | $147 |
| Gilead | 1 | $112 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| PBG Puerto Rico LLC | 4 | $74 |
| Wyeth Puerto Rico Inc | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Exact Sciences | 1 | $25 |
| Amgen | 1 | $20 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,082 in reported general payments places this provider in the 90th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 26 | $688,347 |
| Humira(Cf) PenAdalimumab | 26 | $193,484 |
| RinvoqUpadacitinib | 13 | $129,633 |
| LinzessLinaclotide | 75 | $41,940 |
| SuprepSodium, Potassium,mag Sulfates | 215 | $25,311 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 186 | $14,916 |
| Dexlansoprazole DrDexlansoprazole | 54 | $10,958 |
| Sucralfate | 99 | $5,201 |
| Pantoprazole Sodium | 610 | $5,002 |
| Famotidine | 165 | $1,148 |
| Omeprazole | 90 | $805 |
| Lansoprazole | 39 | $675 |
| Dicyclomine Hcl | 66 | $546 |
| Midazolam HclMidazolam Hcl/Pf | 161 | $522 |
| Midazolam Hcl | 129 | $423 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $3,032 | $688,34726 claims |
| AbbVieRinvoq, Linzess | $10,335 | $171,57288 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 198 gastroenterology providers in Puerto Rico.
Other gastroenterology in Guaynabo
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Rafael Pastrana LabordeHato Rey$76K
- Miguel de Varona-NegronCaguas$68K
- Marcia Cruz CorreaSan Juan$62K
- Francisco CebolleroMayaguez$52K
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
- Hector LozanoSan Juan$28K
- Carlos MicamesMayaguez$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.